{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:38:45Z","timestamp":1776087525998,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2024.1382858","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:06:17Z","timestamp":1709701577000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence"],"prefix":"10.3389","volume":"12","author":[{"given":"Carina","family":"Slidsborg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair","family":"Fielder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/0002-9394(52)91140-9","article-title":"Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations","volume":"35","author":"Patz","year":"1952","journal-title":"Am J Ophthalmol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF02482615","article-title":"Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP)","volume":"74","author":"Palmer","year":"1990","journal-title":"Doc Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41390-023-02568-4","article-title":"Retinopathy of prematurity protection conferred by uteroplacental insufficiency through erythropoietin signaling in an experimental murine model","volume":"94","author":"Fung","year":"2023","journal-title":"Pediatr Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ajo.2023.12.008","article-title":"Extending peripheral retinal vascularization in retinopathy of prematurity through regulation of VEGF signaling","volume":"260","author":"Sauer","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s40123-023-00744-7","article-title":"Laser versus anti-VEGF: a paradigm shift for treatment-warranted retinopathy of prematurity","volume":"12","author":"Hartnett","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.64.4.9","article-title":"Prenatal carotenoid supplementation with lutein or zeaxanthin ameliorates oxygen-induced retinopathy (OIR) in Bco2-\/- macular pigment mice","volume":"64","author":"Arunkumar","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/978-1-61779-606-7_28","article-title":"The role of reactive oxygen species and oxidative signaling in retinopathy of prematurity","volume-title":"Studies on Retinal and Choroidal Disorders","author":"Hartnett","year":"2012"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10633-009-9181-x","article-title":"The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50\/10 OIR model","volume":"120","author":"Elizabeth Hartnett","year":"2010","journal-title":"Doc Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10456-018-9618-5","article-title":"Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy","volume":"21","author":"Simmons","year":"2018","journal-title":"Angiogenesis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ophtha.2015.12.019","article-title":"Neonatal risk factors for treatment-demanding retinopathy of prematurity: a danish national study","volume":"123","author":"Slidsborg","year":"2016","journal-title":"Ophthalmology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/11206721221126286","article-title":"Systematic review of the guidelines for retinopathy of prematurity","volume":"33","author":"Ko\u015bci\u00f3\u0142ek","year":"2023","journal-title":"Eur J Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archopht.125.7.875","article-title":"Interexpert agreement of plus disease diagnosis in retinopathy of prematurity","volume":"125","author":"Chiang","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/bjophthalmol-2011-300573","article-title":"Experts do not agree when to treat retinopathy of prematurity based on plus disease","volume":"96","author":"Slidsborg","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of prematurity, third edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3390\/app13053211","article-title":"Applications of artificial intelligence in neonatology","volume":"13","author":"Chioma","year":"2023","journal-title":"Applied Sciences (Switzerland)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2018-313156","article-title":"Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity","volume":"103","author":"Redd","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaophthalmol.2022.2135","article-title":"External validation of a retinopathy of prematurity screening model using artificial intelligence in 3 low- and middle-income populations","volume":"140","author":"Coyner","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.clp.2014.08.011","article-title":"Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity","volume":"41","author":"Hartnett","year":"2014","journal-title":"Clin Perinatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/ICU.0000000000000360","article-title":"Role of cytokines and treatment algorithms in retinopathy of prematurity","volume":"28","author":"Hartnett","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41598-018-20278-4","article-title":"Targeted knockdown of overexpressed VEGFA or VEGF164 in muller cells maintains retinal function by triggering different signaling mechanisms","volume":"8","author":"Becker","year":"2018","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1167\/iovs.13-11625","article-title":"Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity","volume":"54","author":"McCloskey","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B25","first-page":"1577","article-title":"Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity","volume":"17","author":"Hartmann","year":"2011","journal-title":"Mol Vis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/pr.2015.181","article-title":"Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity","volume":"79","author":"Hellgren","year":"2016","journal-title":"Pediatr Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/archophthalmol.2009.69","article-title":"Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I","volume":"127","author":"Lofqvist","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstrom","year":"2003","journal-title":"Pediatrics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41390-021-01528-0","article-title":"Blood protein profiles related to preterm birth and retinopathy of prematurity","volume":"91","author":"Danielsson","year":"2022","journal-title":"Pediatr Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms23137354","article-title":"RNA-Seq Provides insights into VEGF-induced signaling in human retinal microvascular endothelial cells: implications in retinopathy of prematurity","volume":"23","author":"Ramshekar","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1382858\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:06:21Z","timestamp":1709701581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1382858\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":30,"alternative-id":["10.3389\/fped.2024.1382858"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1382858","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"article-number":"1382858"}}